Dexcom (DXCM) Tax Provisions (2012 - 2026)

Dexcom (DXCM) has 13 years of Tax Provisions data on file, last reported at $70.0 million in Q1 2026.

• Tax Provisions for Q1 2026 came in at $70.0 million, up 43.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $273.2 million (up 39.67% YoY), and the FY2025 annual result was $252.1 million, up 89.83% from the prior year.
• Tax Provisions fell to $70.0 million in Q1 2026 per DXCM's latest filing, from $73.4 million in the prior quarter.
• Over five years, Tax Provisions peaked at $119.7 million in Q3 2023 and troughed at -$61.2 million in Q1 2022.
• A 5-year average of $39.6 million and a median of $44.3 million in 2024 frame the typical range for Tax Provisions.
• The sharpest annual moves came in 2022 and 2024: Tax Provisions slumped 302.63% in 2022, then jumped 690.1% in 2024.
• A 5-year view of Tax Provisions shows it stood at $41.4 million in 2022, then sank by 124.4% to -$10.1 million in 2023, then jumped by 690.1% to $59.6 million in 2024, then gained by 23.15% to $73.4 million in 2025, then fell by 4.63% to $70.0 million in 2026.
• Business Quant data shows DXCM's Tax Provisions at $70.0 million in Q1 2026, $73.4 million in Q4 2025, and $68.5 million in Q3 2025.